Leptomeningeal Carcinomatosis Terminated Phase 1 Trials for RTA 744 (DB05920)

IndicationStatusPhase
DBCOND0038074 (Leptomeningeal Carcinomatosis)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00527410A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic MeningitisTreatment